930 likes | 1.18k Views
Patent Information Indiana University 17 September, 2002. Ron Kaminecki Dialog – A Thomson Company ron.kaminecki@dialog.com. Intent. To learn about the patent process To be able to read a patent To understand why they are written the way that they are written To be able to find patents.
E N D
Patent Information Indiana University17 September, 2002 Ron Kaminecki Dialog – A Thomson Company ron.kaminecki@dialog.com
Intent • To learn about the patent process • To be able to read a patent • To understand why they are written the way that they are written • To be able to find patents
Types of Intellectual Property • Patents • Trademarks • Copyrights • Trade Secrets
Patents • Keep others from making, using, selling, importing your invention • You must make an “enabling disclosure,” including a “best mode” for practicing the invention • This protection, plus the best mode information make patents a source of competitive information
Patentability • Novel • Useful • Non-Obvious
Is this patentable? • I created a black powder that lowers fever in humans • The powder has no side effects • But, it takes a week to make a batch
DIALOG(R)File 351:Derwent WPI(c) 2002 Thomson Derwent. All rts. reserv.008610382WPI Acc No: 1991-114412/199116XRAM Acc No: C91-049296 Antipyretic prodn - by continuously heating live mole in clay-ware buried in ash -and grinding dead molePatent Assignee: KIBA T (KIBA-I)Number of Countries: 001 Number of Patents: 002Patent Family:Patent No Kind Date Applicat No Kind Date WeekJP 3056421 A 19910312 JP 89190307 A 19890721 199116 BJP 94051630 B2 19940706 JP 89190307 A 19890721 199425Abstract (Basic): JP 3056421 A Prepn. comprises continuously heating a live mole (sic) in clay ware buried in ash for a week and grinding the dead mole into black powder. USE/ADVANTAGE - The drug obtained works rapidly as an antipyretic and causes no side reactions. The drug showed rapid antipyretic effects in patients with fever of 38 to 40 deg.C. associated with a common cold.
DIALOG(R)File 351:Derwent WPI(c) 2002 Thomson Derwent. All rts. reserv.008610382WPI Acc No: 1991-114412/199116XRAM Acc No: C91-049296 Antipyretic prodn - by continuously heating live mole in clay-ware buried in ash -and grinding dead molePatent Assignee: KIBA T (KIBA-I)Number of Countries: 001 Number of Patents: 002Patent Family:Patent No Kind Date Applicat No Kind Date WeekJP 3056421 A 19910312 JP 89190307 A 19890721 199116 BJP 94051630 B2 19940706 JP 89190307 A 19890721 199425Abstract (Basic): JP 3056421 APrepn. comprises continuously heating a live mole (sic) in clay ware buried in ash for a week and grinding the dead mole into black powder. USE/ADVANTAGE - The drug obtained works rapidly as an antipyretic and causes no side reactions. The drug showed rapid antipyretic effects in patients with fever of 38 to 40 deg.C. associated with a common cold.
Types of patents • Product • Process • Improvement • Machine • Item of manufacture (e.g., rug) • New use
Kinds of patents • Utility • Chemical • Electrical • Mechanical • Plant • Design
Markush claims • Typically in chemical cases • Allows broad claiming of many species of related compounds
Markush claim DETAILED DESCRIPTION - 2,3-benzodiazepine derivatives of formula (I) and their acid addition salts are new. X=H, Cl or OCH3; Y=H or halo; Z=methyl or Cl; R=1-4C alkyl or NR1R2; and R1, R2 =H, 1-4C alkyl, 1-4C alkoxy or 3-6C cycloalkyl.
Is this patentable? • You make a composition consisting of cayenne pepper and other kitchen spices • You put it into someone’s shoes
Patent information backgrounder • Business information can be found in many fields in a patent • Can also take advantage of timing differences to “predict” a patent publishing elsewhere
Patentees that have cited Quaker RANK No. Items in File Items Ranked %Items Ranked Term-------- ------------- ------------ ------------- ---- 1 496046 539 23.3% UNASSIGNED 2 576 103 04.5% QUAKER OATS 3 410 65 02.8% NABISCO BRANDS 4 451 46 02.0% GENERAL MILLS 5 564 32 01.4% MATTEL, INC 6 140 28 01.2% LITTLE TIKES CO 7 735 25 01.1% INTERLEGO AG CH 8 962 21 00.9% NESTEC S A CH 9 1119 21 00.9% UNION OIL CO 10 60 19 00.8% HESTAIR • 11 14990 17 00.7% SONY CORP JP 12 82 16 00.7% FISHER PRICE INC 13 155 16 00.7% INTERLEGO A.G. 14 776 15 00.6% NABISCO, INC. 15 43 15 00.6% TODAY S KIDS INC 16 169 15 00.6% TOMY CO LTD JP 17 106 14 00.6% COSCO INC 18 5749 14 00.6% PROCTER & GAMBLE 19 315 14 00.6% TAKARA CO LTD JP 20 244 14 00.6% THE PILLSBURY CO 21 258 13 00.6% PILLSBURY CO THE • . • . • . 50 43 10 00.4% GERRY BABY PROD
Companies in litigation with Quaker Oats • RANK No. Items Term-------- ----- ---- 1 20 QUAKER OATS CO 2 4 FISHER-PRICE INC 3 2 FABWELL INC 4 2 GENERAL FOODS CORP 5 2 GENERAL MILLS INC 6 2 LUND INDUSTRIES 7 2 RUBBERMAID INCROPORATED 8 1 BEECHAM GROUP 9 1 BROOKFIELD ATHLETIC CO INC 10 1 BUSH BROS & CO 11 1 DEJAY CORP 12 1 HORTON CO 13 1 ISLAND MERCHANDISE CO LTD 14 1 KWIK-FIND INC 15 1 LILLIAN VERNON CORP 16 1 LITTLE PEOPLE SEATS INCORPORATED 17 1 MALT-O-MEAL CO 18 1 MATTEL INC 19 1 MIDDLEBY JOSEPH JR INC 20 1 SANDS TAYLOR & WOOD CO 21 1 SANKYO COMPANY 22 1 SPANG & CO 23 1 STOKELY-VAN CAMP INC 24 1 TAURUS INTERNATIONAL INCORPORATED 25 1 THE GATORADE COMPANY INC 26 1 TITAN TIRE CORPORATION 27 1 TITAN WHEEL INTERNATIONAL INCORPORATED 28 1 TODAYS KIDS INC
Patents can have siblings/children • Division • Continuation • Continuation in part
Original application Division
Original application Division Continuation in part
Original application Division Continuation in part Continuation
Original application Division Continuation in part Continuation
Original application Division Continuation Continuation in part Continuation
Original application Division Continuation Continuation in part Division Continuation
Original application Division Continuation Continuation in part Division Continuation CIP
Original application Division Continuation Continuation in part Division Continuation CIP
Original application Division Continuation Continuation in part Division Continuation CIP Each application has its own application number, and if it claims an earlier priority, it will have another number – the priority number
A history of one of Jerome Lemelson’s patents Publication Application Filing Number Kind Date Number Date -------------- -- -------- -------------- --------Main Patent US 6169840 A 20010102 US 938493 19930125Division US 4984073 A US 86906969 19860915Division US 4338626 A US 7913608 19790216Division US 4148061 A US 77778331 19770316Continuation US 5249045 A US 92826617 19920128Continuation US 5119190 A US 89426080 19891024Continuation US 4660086 A US 85723183 19850415Continuation US 4511918 A US 82394946 19820702Continuation US 4118730 A US 72254710 19720518CIP Abandoned US 63267377 19630311CIP US 3081379 A US 56626211 19561204CIP Abandoned US 54477467 19541224Priority US 938493 19930125 US 92826617 19920128 US 89426080 19891024 US 86906969 19860915 US 85723183 19850415 US 82394946 19820702 US 7913608 19790216 US 77778331 19770316 US 72254710 19720518 US 63267377 19630311 US 56626211 19561204 US 54477467 19541224
A history of one of Jerome Lemelson’s patents Publication Application Filing Number Kind Date Number Date -------------- -- -------- -------------- --------Main Patent US 6169840 A 20010102 US 938493 19930125Division US 4984073 A US 86906969 19860915Division US 4338626 A US 7913608 19790216Division US 4148061 A US 77778331 19770316Continuation US 5249045 A US 92826617 19920128Continuation US 5119190 A US 89426080 19891024Continuation US 4660086 A US 85723183 19850415Continuation US 4511918 A US 82394946 19820702Continuation US 4118730 A US 72254710 19720518CIP Abandoned US 63267377 19630311CIP US 3081379 A US 56626211 19561204CIP Abandoned US 54477467 19541224Priority US 938493 19930125 US 92826617 19920128 US 89426080 19891024 US 86906969 19860915 US 85723183 19850415 US 82394946 19820702 US 7913608 19790216 US 77778331 19770316 US 72254710 19720518 US 63267377 19630311 US 56626211 19561204 US 54477467 19541224
Paris Convention date • You must apply for a patent in every country in which you wish to have a patent within one year of the first filing • Acknowledged by most countries • This prevents an invention from being patented somewhere in the world forever